Article: BRIEFING - ASIA HEALTH - MARCH 30, 2009.

An executive briefing on Health for March 30, 2009, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, commercial intelligence and business opportunities.

AUSTRALIA'S BIOTA IN MFG, MARKETING DEAL WITH DAIICHI SANKYO

MELBOURNE - Anti-infective drug developer Biota Holdings Ltd (ASX:BTA) said on Monday that Japanese pharmaceutical firm Daiichi Sankyo will manufacture and market the anti-flu compound CS-8958 in Japan, pending completion of Phase III clinical trials and registration of the drug.

Biota will receive an undisclosed royalty on sales of the drug and a number of fixed-sum payments upon ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!